RPS15C Antibody

What is RPS15 and why is it a target for antibody development?

RPS15 (Ribosomal Protein S15) is a component of the small (40S) ribosomal subunit. It plays a critical role in the large ribonucleoprotein complex responsible for protein synthesis in cells . The protein is approximately 17 kilodaltons in mass and is highly conserved across species, making it a valuable target for comparative studies across different experimental models . RPS15 is also known by other names including RIG, small ribosomal subunit protein uS19, and 40S ribosomal protein S15 . Antibodies against RPS15 are valuable tools for studying ribosome assembly, protein synthesis dynamics, and cellular stress responses that affect translation.

What are the key differences between antibodies targeting different regions of RPS15?

RPS15 antibodies can be developed against different epitopes of the protein, with N-terminal, middle region, and C-terminal targeting being the most common approaches:

The choice of epitope region can significantly affect experimental outcomes, particularly in co-immunoprecipitation studies where protein-protein interactions might obscure certain regions of RPS15 .

What species reactivity can be expected from RPS15 antibodies?

Most commercially available RPS15 antibodies demonstrate reactivity with human samples, while many also cross-react with mouse and rat orthologs due to high sequence conservation . Some antibodies, particularly those targeting highly conserved epitopes, may show broader reactivity across species including pig, zebrafish, bovine, sheep, dog, chicken, and Xenopus . C-terminal targeting antibodies often display broader cross-reactivity due to the higher evolutionary conservation of this region . Always verify specific species reactivity in the antibody documentation for your experimental design.

How should RPS15 antibodies be validated before experimental use?

A rigorous validation protocol for RPS15 antibodies should include:

• Western blot analysis with positive control samples (e.g., A549, HepG2, U-87 MG, or MCF7 cell lysates) to confirm the expected 17 kDa band size

• Knockout/knockdown validation to confirm specificity

• Peptide competition assay to verify epitope specificity

• Cross-reactivity testing against closely related ribosomal proteins

• Application-specific validation for intended use (IHC, ICC, Flow, etc.)

For C-terminal targeting antibodies specifically, validation should include comparison with N-terminal targeting antibodies to ensure complete protein detection rather than degradation products.

What are the optimal conditions for using RPS15 antibodies in Western blotting?

For optimal Western blot results with RPS15 antibodies:

• Use appropriate lysis buffers that preserve ribosomal integrity (RIPA buffer with protease inhibitors is often suitable)

• Load 10-20 μg of total protein per lane

• For monoclonal antibodies like EPR11104, a 1:1000 dilution typically produces optimal results

• For polyclonal antibodies, concentrations between 1:500-1:2000 should be tested

• Secondary antibody (e.g., goat anti-rabbit HRP-conjugated) at 1:2000-1:5000 dilution

• Expect a band at approximately 17 kDa, though higher molecular weight bands may indicate post-translational modifications or complexes

• Include positive control lysates such as A549, HepG2, U-87 MG, or MCF7 cells

C-terminal targeting antibodies may require special consideration if the protein undergoes C-terminal processing in your experimental system.

What are the recommended protocols for immunohistochemistry with RPS15 antibodies?

For successful immunohistochemistry using RPS15 antibodies:

• Perform heat-mediated antigen retrieval before commencing with the IHC staining protocol

• For paraffin-embedded tissues, a dilution of 1:100 for monoclonal antibodies like EPR11104 is typically effective

• For frozen sections, optimization may require testing dilutions from 1:50-1:200

• Include positive control tissues with known RPS15 expression

• Always run negative controls (primary antibody omission and isotype controls)

• For C-terminal targeting antibodies, consider that accessibility may be affected by tissue fixation methods

• When using automated staining platforms, validate protocols specifically for RPS15 detection

How can RPS15 antibodies be employed in studying ribosome biogenesis defects?

RPS15 antibodies are valuable tools for investigating ribosome biogenesis defects:

• Nucleolar stress detection: Monitor RPS15 localization changes during nucleolar stress using immunofluorescence with anti-RPS15 antibodies

• Pre-ribosomal particle analysis: Use RPS15 antibodies in co-immunoprecipitation to isolate pre-40S particles

• Ribosome assembly checkpoint investigation: Compare distribution of RPS15 in nuclear and cytoplasmic fractions

• Pulse-chase experiments: Combine metabolic labeling with immunoprecipitation using RPS15 antibodies to track newly synthesized ribosomal subunits

• SILAC-based proteomics: Use RPS15 antibodies to pull down associated proteins in normal vs. pathological conditions

C-terminal specific antibodies may provide advantages when studying the integration of RPS15 into the ribosomal structure, as the C-terminus is often involved in important structural interactions .

What are the limitations and pitfalls when using RPS15 antibodies in multiplex immunofluorescence?

When conducting multiplex immunofluorescence with RPS15 antibodies, researchers should be aware of these challenges:

• Epitope masking: RPS15's incorporation into the ribosome may mask certain epitopes, particularly in fixed tissues

• High background: The abundance of ribosomes can lead to high background signal requiring careful optimization of antibody dilutions

• Cross-reactivity with other RPs: Ensure the selected antibody doesn't cross-react with other ribosomal proteins, particularly those with structural similarity

• Fixation sensitivity: Different fixation methods can affect epitope accessibility; C-terminal antibodies may perform differently under various fixation conditions

• Steric hindrance in multiplex setups: When using multiple antibodies, ensure RPS15 antibody doesn't interfere with other detection reagents

• Autofluorescence interference: Ribosome-rich tissues may exhibit high autofluorescence requiring appropriate controls and quenching protocols

How do post-translational modifications of RPS15 affect antibody recognition?

Post-translational modifications (PTMs) of RPS15 can significantly impact antibody recognition:

For comprehensive analysis of modified RPS15, consider using multiple antibodies targeting different regions or combining immunoprecipitation with mass spectrometry.

What are common causes of false negatives when using RPS15 antibodies?

Several factors can contribute to false negative results when using RPS15 antibodies:

• Epitope masking: RPS15 incorporation into ribosomes may hide the epitope, particularly problematic for C-terminal antibodies in certain applications

• Inadequate sample preparation: Insufficient lysis or inappropriate buffer composition may limit RPS15 extraction

• Over-fixation in immunohistochemistry: Excessive fixation can cause epitope destruction

• Insufficient antigen retrieval: Particularly important for formalin-fixed paraffin-embedded tissues

• Sub-optimal antibody concentration: Dilutions that are too high may result in undetectable signal

• Degraded protein samples: RPS15 may be sensitive to certain proteases

• Incompatible detection systems: Ensure secondary antibody is appropriate for the primary antibody host species

How can specificity of RPS15 antibodies be confirmed in experimental systems?

To confirm the specificity of RPS15 antibodies in your experimental system:

• CRISPR/Cas9 knockout validation: Generate RPS15 knockout cells (temporary knockdown may be necessary as complete knockout may be lethal)

• siRNA knockdown: Confirm reduced signal correlates with reduced protein expression

• Peptide competition assay: Pre-incubate antibody with immunizing peptide to block specific binding

• Orthogonal antibody comparison: Compare results using antibodies targeting different RPS15 epitopes

• Mass spectrometry validation: Confirm identity of immunoprecipitated proteins

• Cross-species reactivity: Test predicted cross-reactivity based on epitope conservation

• Overexpression systems: Test antibody performance in systems with controlled RPS15 overexpression

For C-terminal antibodies specifically, comparing results with N-terminal targeting antibodies can provide confirmation of full-length protein detection.

What quality control measures should be implemented when using RPS15 antibodies for quantitative applications?

For quantitative applications with RPS15 antibodies:

• Standard curve generation: Use recombinant RPS15 protein to create a standard curve for quantification

• Batch consistency testing: Validate new antibody lots against previous ones for consistent performance

• Loading control normalization: Use appropriate loading controls (considering that traditional housekeeping genes may be affected in ribosome-related studies)

• Technical replicates: Run multiple technical replicates to assess assay variability

• Linear dynamic range determination: Establish the linear range of quantification for your specific experimental setup

• Inter-laboratory validation: When possible, confirm critical findings using the same antibody in different laboratory settings

• Regular positive control inclusion: Include characterized positive controls in each experiment

How are RPS15 antibodies being utilized in cancer research?

RPS15 antibodies are becoming increasingly important in cancer research:

• Diagnostic marker exploration: Investigating altered RPS15 expression in different cancer types

• Ribosomopathy studies: Examining ribosomal dysfunction in cancers with RPS15 mutations

• Therapy response monitoring: Tracking changes in ribosome composition during treatment

• Cancer stem cell characterization: Analyzing specialized ribosomes in cancer stem cells

• Immunotherapy research: Investigating ribosomal proteins as potential tumor-associated antigens

• Drug mechanism studies: Understanding how certain anticancer compounds affect ribosome biogenesis

Recent findings suggest RPS15 mutations in chronic lymphocytic leukemia may have prognostic significance, making detection with specific antibodies particularly valuable in hematological malignancy research.

What considerations are important when using RPS15 antibodies in single-cell techniques?

When incorporating RPS15 antibodies into single-cell analysis techniques:

• Signal amplification needs: Due to limited material, signal amplification strategies may be necessary

• Cell fixation optimization: Balance between antigen preservation and cellular permeabilization

• Multiplexing compatibility: Ensure compatibility with other antibodies in multiparameter analyses

• Validation at single-cell level: Specifically validate antibody performance in single-cell applications

• Background minimization: Implement rigorous controls to distinguish true signal from background

• Flow cytometry optimization: For intracellular flow cytometry, optimize fixation and permeabilization protocols specifically for RPS15 detection

• Imaging mass cytometry considerations: When applicable, validate metal-conjugated RPS15 antibodies

Single-cell techniques may require higher antibody concentrations than bulk applications to achieve detectable signal.